Benzinga
Benzinga
Benzinga
martedì, settembre 29

Minimed Group Inc

MMEDNASDAQ
Trade with Public
Trade with Public
$20.04
-0.45-2.2%
In chiusura: Sep 29, 5:00 PM EST
$20.04
N/A
Post-mercato: 4:00 PM EST
PanoramicaNotiziePrevisioni utiliEventiObiettivi di prezzoDati finanziariSentimentConfrontaOpzioniRapporto azionario

Minimed Group Analyst Price Targets

Wall Street analyst price targets and consensus rating for Minimed Group (MMED).

Price Target Range — 3 Quarters

Analyst Consensus — 13 Analysts

12Buy
1Hold
Consensus RatingBuy# Analysts13Avg. Consensus PT$25Upside to Avg. PT+25.1%

Rating Trend — Last 9 Months

Recent Analyst Actions

Visualizza tutte le valutazioni →
DateFirmAnalystActionRating ChangePrice Target
Sep 24, 2026Truist SecuritiesRichard NewitterInitiateBuy$29
Sep 3, 2026Morgan StanleyKallum TitchmarshPT RaiseOverweight$19→$21
More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
Truist Securities Initiates Coverage On Minimed Group with Buy Rating, Announces Price Target of $29

Truist Securities analyst Richard Newitter initiates coverage on Minimed Group (NASDAQ:MMED) with a Buy rating and announces Price Target of $29.
Benzinga Newsdesk

PRO
Morgan Stanley Maintains Overweight on Minimed Group, Raises Price Target to $21

Morgan Stanley analyst Kallum Titchmarsh maintains Minimed Group (NASDAQ:MMED) with a Overweight and raises the price target from $19 to $21.
Benzinga Newsdesk

PRO
Citigroup Maintains Buy on Minimed Group, Raises Price Target to $26

Citigroup analyst Joanne Wuensch maintains Minimed Group (NASDAQ:MMED) with a Buy and raises the price target from $23 to $26.
Benzinga Newsdesk

PRO
Evercore ISI Group Maintains Outperform on Minimed Group, Raises Price Target to $27

Evercore ISI Group analyst Daniel Markowitz maintains Minimed Group (NASDAQ:MMED) with a Outperform and raises the price target from $20 to $27.
Benzinga Newsdesk

PRO
Wells Fargo Maintains Overweight on Minimed Group, Raises Price Target to $26

Wells Fargo analyst Larry Biegelsen maintains Minimed Group (NASDAQ:MMED) with a Overweight and raises the price target from $22 to $26.
Benzinga Newsdesk

These Analysts Boost Their Forecasts On MiniMed Group Following Q1 Sales Results

MiniMed Group beat Q1 sales estimates with 16.6% growth to $843M; shares rose 7.1% as analysts raised price targets to $26-$28.
Avi Kapoor

Dati e API: API Benzinga · API notizie azionarie · API valutazioni analisti · API logo aziende

Dati di mercato forniti da API Benzinga

Benzinga

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO

© 2026 Benzinga | All Rights Reserved